Ankle Tracking Training in Stroke
|ClinicalTrials.gov Identifier: NCT01298583|
Recruitment Status : Completed
First Posted : February 17, 2011
Last Update Posted : January 10, 2012
The purpose of this study is to compare the improvement in ankle control and brain activation in subjects with stroke resulting from two different forms of telerehabilitation: tracking training, emphasizing accurate movements, versus movement training, involving simple movements.
- The Track group will show greater improvement in ankle range of motion compared to the Move group.
- The Track group will show greater improvement in ankle tracking accuracy and greater changes in fMRI (increase in relative volume of activation for ipsilesional sensorimotor cortex, increase in laterality index, and decrease in blood-oxygen-level-dependent (BOLD) signal intensity index) compared to Move group.
- The Track group will show greater improvement in tracking accuracy at an untrained joint (knee) compared to the Move group.
- The Track group will show greater improvement in standing balance.
- The Track group will show greater improvement in walking speed and ankle dorsiflexion during gait compared to the Move group.
|Condition or disease||Intervention/treatment||Phase|
|Stroke||Behavioral: ankle tracking training||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||16 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Ankle Tracking Training in Stroke|
|Study Start Date :||January 2007|
|Actual Primary Completion Date :||January 2008|
|Actual Study Completion Date :||December 2010|
Experimental: ankle tracking
subjects track a target with ankle movement
Behavioral: ankle tracking training
one group will use the ankle for tracking, the other group will use the ankle for simple movement
|No Intervention: ankle movement|
- ankle range of motion [ Time Frame: Measurement at pretest, posttest and followup ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01298583
|United States, Minnesota|
|University of Minnesota|
|Minneapolis, Minnesota, United States, 55455|
|Principal Investigator:||James Carey, PhD||University of Minnesota - Clinical and Translational Science Institute|